HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 4, 1985-1991, January 25, 2008

This Article Full Text Full Text (PDF) All Versions of this Article: 283/4/1985    most recent M708160200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, E. Articles by Baenziger, J. U. Search for Related Content PubMed PubMed Citation Articles by Miller, E. Articles by Baenziger, J. U. Social Bookmarking                      What's this?

A Necessary and Sufficient Determinant for Protein-selective Glycosylation in Vivo^*

From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110

A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear N-linked oligosaccharides that are modified with β1,4-linked N-acetylgalactosamine (GalNAc). The selective addition of GalNAc to these glycoproteins requires that the β1,4-N-acetylgalactosaminyltransferase (βGT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned βGTs, βGT3 and βGT4, that are able to transfer GalNAc to GlcNAc in β1,4-linkage display the necessary glycoprotein specificity in vivo. Both βGTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone subunit and CA6 but not to those on transferrin (Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both βGT3 and βGT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by βGT3 and βGT4.

Received for publication, October 2, 2007 , and in revised form, November 28, 2007.

^* This work was supported by National Institutes of Health Grant R01DK41738 (to J. U. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Present address: Graduate School of Biomedical Sciences, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Dr., MC 7819, San Antonio, TX 78229-3900.

² Present address: Transkaryotic Therapies, Inc.,700 Main St., Cambridge, MA 02139.

³ To whom correspondence should be addressed: Washington University School of Medicine, Dept. of Pathology and Immunology, 4940 Parkview Place, St. Louis, MO 63110. Fax: 314-362-8888; E-mail: Baenziger{at}wustl.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z. S Kawar, T. K Johnson, S. Natunen, J. B Lowe, and R. D Cummings PSGL-1 from the murine leukocytic cell line WEHI-3 is enriched for core 2-based O-glycans with sialyl Lewis x antigen Glycobiology, June 1, 2008; 18(6): 441 - 446. [Abstract] [Full Text] [PDF]